Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation.

MLA

Lv, Xiaoyu, et al. “Ergothioneine Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Enhancing Autophagy, Inhibiting Oxidative Damage and Inflammation.” Lipids in Health and Disease, vol. 23, no. 1, Nov. 2024, p. 395. EBSCOhost, https://doi.org/10.1186/s12944-024-02382-9.

APA

Lv, X., Nie, C., Shi, Y., Qiao, Q., Gao, J., Zou, Y., Yang, J., Chen, L., & Hou, X. (2024). Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation. Lipids in Health and Disease, 23(1), 395. https://doi.org/10.1186/s12944-024-02382-9

Chicago

Lv, Xiaoyu, Chenyu Nie, Yihan Shi, Qincheng Qiao, Jing Gao, Ying Zou, Jingwen Yang, Li Chen, and Xinguo Hou. 2024. “Ergothioneine Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Enhancing Autophagy, Inhibiting Oxidative Damage and Inflammation.” Lipids in Health and Disease 23 (1): 395. doi:10.1186/s12944-024-02382-9.